Thorac Cardiovasc Surg
DOI: 10.1055/a-2625-9617
Original Cardiovascular

Totally Thoracoscopic Ablation for Atrial Fibrillation: All-Box Clamping

A Study from the German Cardiosurgical Atrial Fibrillation Registry
Nicolas Doll
1   Department of Cardiac Surgery, Integrated Heart Center, Schuechtermann-Klinik Bad Rothenfelde, Bad Rothenfelde, Germany
,
Antonia Doll
2   Faculty of Medicine, Georg-August-Universität Göttingen, Göttingen, Germany
,
Geza Horvath
1   Department of Cardiac Surgery, Integrated Heart Center, Schuechtermann-Klinik Bad Rothenfelde, Bad Rothenfelde, Germany
,
Gerold Mönnig
3   Department of Cardiology, Integrated Heart Center, Schuechtermann-Klinik Bad Rothenfelde, Bad Rothenfelde, Germany
,
Christian Pott
3   Department of Cardiology, Integrated Heart Center, Schuechtermann-Klinik Bad Rothenfelde, Bad Rothenfelde, Germany
,
Thorsten Hanke
4   Department of Cardiac Surgery, Asklepios Klinikum Hamburg, Hamburg, Germany
,
Taoufik Ouarrak
5   Stiftung Institute für Herzinfarktforschung, Ludwigshafen am Rhein, Germany
,
Jochen Senges
5   Stiftung Institute für Herzinfarktforschung, Ludwigshafen am Rhein, Germany
,
1   Department of Cardiac Surgery, Integrated Heart Center, Schuechtermann-Klinik Bad Rothenfelde, Bad Rothenfelde, Germany
› Author Affiliations

Funding The CASE-AF registry has been supported by a grant from Atricure Europe BV, De Entree 260, 1101 EE Amsterdam Z. O. This work itself received no additional funding.

Abstract

Background

Epicardial surgical ablation is an effective strategy to treat non-paroxysmal forms of atrial fibrillation. Current thoracoscopic epicardial surgical strategies are complex, and are therefore often avoided. With slight modifications to the thoracoscopic maze procedure, totally thoracoscopic all-box clamping may facilitate the performance of epicardial thoracoscopic ablation, while maintaining good results.

Methods

Between December 2023 and December 2024, 42 patients underwent thoracoscopic all-box clamping at a single center. All-box clamping uses commercially available bipolar radiofrequency clamps for isolation of the ipsilateral pulmonary veins and posterior left atrial wall through right and then left-sided thoracoscopic access. The left atrial appendage is occluded using a clip device, and the ligament of Marshall is transected. Assessment of a bidirectional block confirmed electrical isolation. Data from the CASE-AF registry were analyzed retrospectively. Short-term results pertaining to efficacy and safety are provided.

Results

All-box clamping was successfully offered to all patients by three surgeons. There were no reported major or minor complications. The median hospital stay was 6 days (interquartile range 5–6). At discharge, a sinus rhythm was observed in 92.9%, and in 76.1% of patients off any class I/III antiarrhythmic drugs.

Conclusion

Surgical ablation with a modified thoracoscopic technique is safe and feasible for the treatment of atrial fibrillation.

Authors' Contribution

Study design: N.D., G.M., C.P., T.H., J.S., and M.W.; Data acquisition: N.D., A.D., G.H., G.M., C.P., T.H., T.O., and M.W.; data analysis and interpretation: A.D., G.H., T.O., J.S., and M.W.; manuscript drafting: A.D., G.H., J.S., and M.W.; statistical analysis: T.O. and M.W.; critical revision: N.D., G.M., C.P., J.S., and T.H.; accountability: N.D., A.D., G.H., G.M., C.P., T.H., T.O., J.S., and M.W.




Publication History

Received: 29 March 2025

Accepted: 01 June 2025

Accepted Manuscript online:
03 June 2025

Article published online:
27 June 2025

© 2025. Thieme. All rights reserved.

Georg Thieme Verlag KG
Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany

 
  • References

  • 1 DeLurgio DB, Crossen KJ, Gill J. et al. Hybrid convergent procedure for the treatment of persistent and long-standing persistent atrial fibrillation: results of CONVERGE clinical trial. Circ Arrhythm Electrophysiol 2020; 13 (12) e009288
  • 2 van der Heijden CAJ, Weberndörfer V, Vroomen M. et al. Hybrid ablation versus repeated catheter ablation in persistent atrial fibrillation: a randomized controlled trial. JACC Clin Electrophysiol 2023; 9 (7 Pt 2): 1013-1023
  • 3 Doll N, Weimar T, Kosior DA. et al. Efficacy and safety of hybrid epicardial and endocardial ablation versus endocardial ablation in patients with persistent and longstanding persistent atrial fibrillation: a randomised, controlled trial. EClinicalMedicine 2023; 61: 102052
  • 4 Pison L, La Meir M, van Opstal J, Blaauw Y, Maessen J, Crijns HJ. Hybrid thoracoscopic surgical and transvenous catheter ablation of atrial fibrillation. J Am Coll Cardiol 2012; 60 (01) 54-61
  • 5 Maesen B, Pison L, Vroomen M. et al. Three-year follow-up of hybrid ablation for atrial fibrillation. Eur J Cardiothorac Surg 2018; 53 (Suppl. 01) i26-i32
  • 6 Weimar T, Vosseler M, Czesla M, Boscheinen M, Hemmer WB, Doll KN. Approaching a paradigm shift: endoscopic ablation of lone atrial fibrillation on the beating heart. Ann Thorac Surg 2012; 94 (06) 1886-1892
  • 7 van Laar C, Kelder J, van Putte BP. The totally thoracoscopic maze procedure for the treatment of atrial fibrillation. Interact Cardiovasc Thorac Surg 2017; 24 (01) 102-111
  • 8 Vos LM, Kotecha D, Geuzebroek GSC. et al. Totally thoracoscopic ablation for atrial fibrillation: a systematic safety analysis. Europace 2018; 20 (11) 1790-1797
  • 9 Wehbe M, Albert M, Lewalter T. et al; CASE-AF Investigators. The German CArdioSurgEry Atrial Fibrillation registry: in-hospital outcomes. Thorac Cardiovasc Surg 2023; 7 (14) 243-254
  • 10 Kirchhof P, Benussi S, Kotecha D. et al; ESC Scientific Document Group. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J 2016; 37 (38) 2893-2962
  • 11 Van Gelder IC, Rienstra M, Bunting KV. et al; ESC Scientific Document Group. 2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 2024; 45 (36) 3314-3414
  • 12 Packer DL, Mark DB, Robb RA. et al; CABANA Investigators. Effect of catheter ablation vs antiarrhythmic drug therapy on mortality, stroke, bleeding, and cardiac arrest among patients with atrial fibrillation: the CABANA randomized clinical trial. JAMA 2019; 321 (13) 1261-1274
  • 13 Kuck K-H, Brugada J, Fürnkranz A. et al; FIRE AND ICE Investigators. Cryoballoon or radiofrequency ablation for paroxysmal atrial fibrillation. N Engl J Med 2016; 374 (23) 2235-2245
  • 14 Clarnette JA, Brooks AG, Mahajan R. et al. Outcomes of persistent and long-standing persistent atrial fibrillation ablation: a systematic review and meta-analysis. Europace 2018; 20 (FI_3): f366-f376
  • 15 Di Biase L, Burkhardt JD, Mohanty P. et al. Left atrial appendage: an underrecognized trigger site of atrial fibrillation. Circulation 2010; 122 (02) 109-118
  • 16 Nazarian S, Markman TM. Mapping endocardial-epicardial dissociation: significance for atrial fibrillation ablation. JACC Clin Electrophysiol 2020; 6 (07) 846-848
  • 17 Kistler PM, Chieng D, Sugumar H. et al. Effect of catheter ablation using pulmonary vein isolation with vs without posterior left atrial wall isolation on atrial arrhythmia recurrence in patients with persistent atrial fibrillation: the CAPLA randomized clinical trial. JAMA 2023; 329 (02) 127-135
  • 18 Verma A, Champagne J, Sapp J. et al. Discerning the incidence of symptomatic and asymptomatic episodes of atrial fibrillation before and after catheter ablation (DISCERN AF): a prospective, multicenter study. JAMA Intern Med 2013; 173 (02) 149-156
  • 19 Verma A, Haines DE, Boersma LV. et al; PULSED AF Investigators. Pulsed field ablation for the treatment of atrial fibrillation: PULSED AF pivotal trial. Circulation 2023; 147 (19) 1422-1432
  • 20 Haldar S, Khan HR, Boyalla V. et al. Catheter ablation vs. thoracoscopic surgical ablation in long-standing persistent atrial fibrillation: CASA-AF randomized controlled trial. Eur Heart J 2020; 41 (47) 4471-4480